See All Slides - tctmd.com

Slides

Presentation TCT 2013

Paravalvular Leak Closure: Approach, acute results and late outcomes

Presenter: Sunil Mankad

October 30, 2013

Presentation TCT 2013

IVUS in Tandem Lesions, Diffuse Disease, and Multivessel Disease

Presenter: Daniel Steinberg

October 30, 2013

Presentation TCT 2013

Mission: Lifeline - Then and Now

Presenter: Alice Jacobs

October 30, 2013

Presentation TCT 2013

What Should the Adult Cardiologist Know about PDA Closure?

Presenter: John Moore

October 30, 2013

Presentation TCT 2013

Interventional Cardiovascular Medicine Perspectives

Presenter: Martin Leon

October 30, 2013

Presentation TCT 2013

Is the Society-Driven Registry Model a Partial Solution? The TVT Registry Case Study

Presenter: David Holmes Jr

October 30, 2013

Presentation TCT 2013

Real-Time Device Surveillance

Presenter: Mladen Vidovich

October 30, 2013

Presentation TCT 2013

Lifelong Learning: Developing New Skills & Staying Current

Presenter: Paul Sorajja

October 30, 2013

Presentation TCT 2013

Renal Denervation Beyond Hypertension: Status Update and Study Pathways for New Clinical Indications

Presenter: Felix Mahfoud

October 30, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Presenter: Daniel Blackman

October 30, 2013

Advertisement

Slides

Paravalvular Leak Closure: Approach, acute results and late outcomes

IVUS in Tandem Lesions, Diffuse Disease, and Multivessel Disease

Mission: Lifeline - Then and Now

What Should the Adult Cardiologist Know about PDA Closure?

Interventional Cardiovascular Medicine Perspectives

Is the Society-Driven Registry Model a Partial Solution? The TVT Registry Case Study

Real-Time Device Surveillance

Lifelong Learning: Developing New Skills & Staying Current

Renal Denervation Beyond Hypertension: Status Update and Study Pathways for New Clinical Indications

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content